Drug Manufacturers - Specialty & Generic | Healthcare
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Market Cap
365645004800
Current Price
677.0
52 Week Range
414.0 - 679.0
Previous Close
666.45
Open
668.0
Sector
Healthcare
Address
Serene Chambers, 2nd Floor Road No. 7 Banjara Hills, Hyderabad, 500034, India
Phone
+91-40398-04333
Fax
+91-40398-04320
Website
https://www.lauruslabs.com
Day Low
665.55
Day High
679.0
Dividend Yield
0.24
PE Ratio
102.57576
Earnings Per Share
6.6
Beta
0.756
EBITDA
10341900288
Book Value
82.94
EPS
10.79788
Name | Title | Age | Year Born |
---|---|---|---|
Dr. Satyanarayana Chava M.Sc., Ph.D. | CEO & Whole Time Director | 63 | 1961 |
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A. | CFO & Whole-Time Director | 59 | 1965 |
Mr. B. V. R. K. Suryadevara Srinivasa Rao | President of Manufacturing and Operations | 56 | 1968 |
Mr. Gogireddy Venkateswar Reddy | VP of Legal, Compliance Officer & Company Secretary | - | - |
Mr. Narasimha Rao Chava | Executive Vice President of Human Resources | 56 | 1968 |
Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D. | Executive Director of Quality & Executive Director | 62 | 1962 |
Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc. | Executive Vice President of Manufacturing | 61 | 1963 |
Mr. Chagarlamudi Sita Ramaiah | Executive Vice President of Finance | 51 | 1973 |
Mr. Nurubasha Babchand | Senior Vice President of Generics | 48 | 1976 |
Mr. Krishna Chaitanya Chava | Executive Director of Synthesis & Executive Director | 34 | 1990 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.